Differential pharmacological actions of methadone and buprenorphine in human embryonic kidney 293 cells coexpressing human μ-opioid and opioid receptor-like 1 receptors

Neurochemical Research

Volumn 36, Issue 11, 2011, Pages 2008-2021

  Lee, Cynthia Wei Sheng ^a   Yan, Jia Ying ^a   Chiang, Yao Chang ^a   Hung, Tsai Wei ^a   Wang, Hung Li ^b   Chiou, Lih Chu ^c   Ho, Ing Kang ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Adenylate cyclase activity; Buprenorphine; Methadone; Morphine; Naloxone; Opioid receptor

Indexed keywords

8 (2,3,3A,4,5,6 HEXAHYDRO 1H PHENALEN 1 YL) 1 PHENYL 1,3,8 TRIAZASPIRO[4.5]DECAN 4 ONE; ADENYLATE CYCLASE; BUPRENORPHINE; METHADONE; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; OPIATE RECEPTOR; OPIOID RECEPTOR LIKE 1 RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELLULAR DISTRIBUTION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SPECIFICITY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; LONG TERM EXPOSURE; MONOTHERAPY; PRIORITY JOURNAL;

ADENYLATE CYCLASE; BUPRENORPHINE; DRUG INTERACTIONS; ENZYME ACTIVATION; HEK293 CELLS; HUMANS; METHADONE; NALOXONE; OPIOID PEPTIDES; RECEPTORS, OPIOID; RECEPTORS, OPIOID, MU;

EID: 80054986133     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-011-0525-z     Document Type: Article

References (66)

1. BN Dhawan F Cesselin R Raghubir, et al. 1996 International union of pharmacology. XII. Classification of opioid receptors Pharmacol Rev 48 567 592 8981566 1:CAS:528:DyaK2sXlsVGgtQ%3D%3D (Pubitemid 27023821)
2. M Satoh M Minami 1995 Molecular pharmacology of the opioid receptors Pharmacol Ther 68 343 364 8788562 10.1016/0163-7258(95)02011-X 1:CAS:528:DyaK28Xis1Ortw%3D%3D (Pubitemid 26020722)
3. K Alfaras-Melainis I Gomes R Rozenfeld, et al. 2009 Modulation of opioid receptor function by protein-protein interactions Front Biosci 14 3594 3607 19273296 10.2741/3474 1:CAS:528:DC%2BD1MXltlWksrg%3D
4. C Mollereau M Parmentier P Mailleux, et al. 1994 ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization FEBS Lett 341 33 38 8137918 10.1016/0014-5793(94)80235-1 1:CAS:528: DyaK2cXksFamurs%3D (Pubitemid 24089185)
5. LC Chiou YY Liao PC Fan, et al. 2007 Nociceptin/orphanin FQ peptide receptors: pharmacology and clinical implications Curr Drug Targets 8 117 135 17266536 10.2174/138945007779315605 1:CAS:528:DC%2BD2sXhtFWqurc%3D (Pubitemid 46043903)
6. M Connor MD Christie 1999 Opioid receptor signalling mechanisms Clin Exp Pharmacol Physiol 26 493 499 10405772 10.1046/j.1440-1681.1999.03049.x 1:CAS:528:DyaK1MXktlCmu7k%3D (Pubitemid 29309619)
7. CJ Evans DE Keith Jr H Morrison, et al. 1992 Cloning of a delta opioid receptor by functional expression Science 258 1952 1955 1335167 10.1126/science.1335167 1:CAS:528:DyaK3sXltlamurg%3D
8. F Meng GX Xie RC Thompson, et al. 1993 Cloning and pharmacological characterization of a rat kappa opioid receptor Proc Natl Acad Sci USA 90 9954 9958 8234341 10.1073/pnas.90.21.9954 1:CAS:528:DyaK2cXpslGisg%3D%3D (Pubitemid 23328229)
9. M Tallent MA Dichter GI Bell, et al. 1994 The cloned kappa opioid receptor couples to an N-type calcium current in undifferentiated PC-12 cells Neuroscience 63 1033 1040 7700508 10.1016/0306-4522(94)90570-3 1:CAS:528:DyaK2MXisFyns78%3D (Pubitemid 24366153)
10. 2+ channels in GH3 cells by cloned mu- and delta-opioid receptors Mol Pharmacol 50 947 956 8863841 1:CAS:528:DyaK28XmsFGgu78%3D (Pubitemid 26347716)
11. 2+ from intracellular stores in transfected neuro2a cells by activation of multiple opioid receptor subtypes Biochem Pharmacol 54 809 818 9353135 10.1016/S0006-2952(97)00243-8 1:CAS:528:DyaK2sXms1WntrY%3D (Pubitemid 27404682)
12. + (GIRK) channel Brain Res Mol Brain Res 45 117 126 9105677 10.1016/S0169-328X(96) 00252-5 1:CAS:528:DyaK2sXhtlygtbo%3D (Pubitemid 27182231)
13. K Fukuda S Kato H Morikawa, et al. 1996 Functional coupling of the delta-, mu-, and kappa-opioid receptors to mitogen-activated protein kinase and arachidonate release in Chinese hamster ovary cells J Neurochem 67 1309 1316 8752140 10.1046/j.1471-4159.1996.67031309.x 1:CAS:528:DyaK28XltlKku74%3D (Pubitemid 26277946)
14. MJ Kreek KS LaForge E Butelman 2002 Pharmacotherapy of addictions Nat Rev Drug Discov 1 710 726 12209151 10.1038/nrd897 1:CAS:528:DC%2BD38XmslamtL4%3D (Pubitemid 37361544)
15. C Haasen W van den Brink 2006 Innovations in agonist maintenance treatment of opioid-dependent patients Curr Opin Psychiatry 19 631 636 17012944 10.1097/01.yco.0000245759.13997.9d (Pubitemid 44520380)
16. K Lutfy S Eitan CD Bryant, et al. 2003 Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors J Neurosci 23 10331 10337 14614092 1:CAS:528:DC%2BD3sXpt1ylurY%3D (Pubitemid 37444610)
17. T Christoph B Kogel K Schiene, et al. 2005 Broad analgesic profile of buprenorphine in rodent models of acute and chronic pain Eur J Pharmacol 507 87 98 15659298 10.1016/j.ejphar.2004.11.052 1:CAS:528:DC%2BD2MXkvVCntQ%3D%3D (Pubitemid 40126844)
18. A Dahan A Yassen R Romberg, et al. 2006 Buprenorphine induces ceiling in respiratory depression but not in analgesia Br J Anaesth 96 627 632 16547090 10.1093/bja/ael051 1:CAS:528:DC%2BD28Xjtlamsr8%3D
19. Gutstein HB, Akil H (2001) Opioid analgesics. In: Goodman LS, Hardman JG, Limbird LE et al (eds) Goodman & Gilman's the pharmacological basis of therapeutics. McGraw-Hill, Medical Pub. Division, New York, pp 569-619
20. P Bloms-Funke C Gillen AJ Schuettler, et al. 2000 Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor Peptides 21 1141 1146 10998549 10.1016/S0196-9781(00)00252-7 1:CAS:528:DC%2BD3cXms1Wrt78%3D
21. F Weiss 2005 Neurobiology of craving, conditioned reward and relapse Curr Opin Pharmacol 5 9 19 15661620 10.1016/j.coph.2004.11.001 1:CAS:528: DC%2BD2MXms1Cmsw%3D%3D (Pubitemid 40124529)
22. CP Bailey M Connor 2005 Opioids: cellular mechanisms of tolerance and physical dependence Curr Opin Pharmacol 5 60 68 15661627 10.1016/j.coph.2004.08. 012 1:CAS:528:DC%2BD2MXms1Cmug%3D%3D (Pubitemid 40124536)
23. SK Sharma WA Klee M Nirenberg 1977 Opiate-dependent modulation of adenylate cyclase Proc Natl Acad Sci USA 74 3365 3369 269396 10.1073/pnas.74.8.3365 1:CAS:528:DyaE2sXlvFelt7Y%3D (Pubitemid 8177777)
24. S Chakrabarti L Wang WJ Tang, et al. 1998 Chronic morphine augments adenylyl cyclase phosphorylation: relevance to altered signaling during tolerance/dependence Mol Pharmacol 54 949 953 9855621 1:CAS:528:DyaK1MXosF2n (Pubitemid 29002036)
25. T Avidor-Reiss I Nevo R Levy, et al. 1996 Chronic opioid treatment induces adenylyl cyclase V superactivation. Involvement of Gbetagamma J Biol Chem 271 21309 21315 8702909 10.1074/jbc.271.35.21309 1:CAS:528: DyaK28XlsVWqtrk%3D (Pubitemid 26292991)
26. T Houtani M Nishi H Takeshima, et al. 2000 Distribution of nociceptin/orphanin FQ precursor protein and receptor in brain and spinal cord: a study using in situ hybridization and X-gal histochemistry in receptor-deficient mice J Comp Neurol 424 489 508 10906715 10.1002/1096- 9861(20000828)424:3<489::AID-CNE7>3.0.CO;2-O 1:CAS:528: DC%2BD3cXlvFyhsLg%3D (Pubitemid 30670446)
27. YX Pan E Bolan GW Pasternak 2002 Dimerization of morphine and orphanin FQ/nociceptin receptors: generation of a novel opioid receptor subtype Biochem Biophys Res Commun 297 659 663 12270145 10.1016/S0006-291X(02)02258-1 1:CAS:528:DC%2BD38XntVymtL4%3D
28. HL Wang CY Hsu PC Huang, et al. 2005 Heterodimerization of opioid receptor-like 1 and mu-opioid receptors impairs the potency of micro receptor agonist J Neurochem 92 1285 1294 15748148 10.1111/j.1471-4159.2004.02921.x 1:CAS:528:DC%2BD2MXislegsbw%3D (Pubitemid 40389199)
29. RM Evans H You S Hameed, et al. 2010 Heterodimerization of ORL1 and opioid receptors and its consequences for N-type calcium channel regulation J Biol Chem 285 1032 1040 19887453 10.1074/jbc.M109.040634 1:CAS:528: DC%2BC3cXkvV2r
30. H Ueda T Yamaguchi S Tokuyama, et al. 1997 Partial loss of tolerance liability to morphine analgesia in mice lacking the nociceptin receptor gene Neurosci Lett 237 136 138 9453234 10.1016/S0304-3940(97)00832-X 1:CAS:528:DyaK2sXnvVSrsb0%3D (Pubitemid 28004975)
31. H Ueda M Inoue H Takeshima, et al. 2000 Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence J Neurosci 20 7640 7647 11027224 1:CAS:528:DC%2BD3cXns1eisLY%3D
32. G Shaw S Morse M Ararat, et al. 2002 Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells FASEB J 16 869 871 11967234 1:CAS:528:DC%2BD38Xktl2rs78%3D
33. K Chaturvedi P Bandari N Chinen, et al. 2001 Proteasome involvement in agonist-induced down-regulation of mu and delta opioid receptors J Biol Chem 276 12345 12355 11152677 10.1074/jbc.M008054200 1:CAS:528:DC%2BD3MXjtFylu74%3D
34. S Titus S Neumann W Zheng, et al. 2008 Quantitative high-throughput screening using a live-cell cAMP assay identifies small-molecule agonists of the TSH receptor J Biomol Screen 13 120 127 18216391 10.1177/1087057107313786 1:CAS:528:DC%2BD1cXjtFCitbo%3D (Pubitemid 351248693)
35. D Gabriel M Vernier MJ Pfeifer, et al. 2003 High throughput screening technologies for direct cyclic AMP measurement Assay Drug Dev Technol 1 291 303 15090194 10.1089/15406580360545107 1:CAS:528:DC%2BD3sXjtlyjs78%3D
36. BA Jordan LA Devi 1999 G-protein-coupled receptor heterodimerization modulates receptor function Nature 399 697 700 10385123 10.1038/21441 1:CAS:528:DyaK1MXkt1Snsbc%3D (Pubitemid 29289066)
37. F Jenck J Wichmann FM Dautzenberg, et al. 2000 A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat Proc Natl Acad Sci USA 97 4938 4943 10758169 10.1073/pnas.090514397 1:CAS:528: DC%2BD3cXivFKisro%3D (Pubitemid 30238661)
38. T Avidor-Reiss M Bayewitch R Levy, et al. 1995 Adenylylcyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment J Biol Chem 270 29732 29738 8530363 10.1074/jbc.270.50.29732 1:CAS:528:DyaK2MXhtVSitb3I
39. I Gomes BA Jordan A Gupta, et al. 2000 Heterodimerization of mu and delta opioid receptors: a role in opiate synergy J Neurosci 20 RC110 11069979 1:STN:280:DC%2BD3M7itFGmsw%3D%3D
40. M Pfeiffer T Koch H Schroder, et al. 2002 Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization J Biol Chem 277 19762 19772 11896051 10.1074/jbc.M110373200 1:CAS:528:DC%2BD38XksVWksL8%3D (Pubitemid 34967492)
41. M Pfeiffer S Kirscht R Stumm, et al. 2003 Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization J Biol Chem 278 51630 51637 14532289 10.1074/jbc.M307095200 1:CAS:528: DC%2BD3sXpslOgs70%3D (Pubitemid 38020408)
42. M Hojo Y Sudo Y Ando, et al. 2008 mu-Opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis J Pharmacol Sci 108 308 319 19008645 10.1254/jphs.08244FP 1:CAS:528:DC%2BD1cXhsVKgtL3M
43. H Schroder DF Wu A Seifert, et al. 2009 Allosteric modulation of metabotropic glutamate receptor 5 affects phosphorylation, internalization, and desensitization of the micro-opioid receptor Neuropharmacology 56 768 778 19162047 10.1016/j.neuropharm.2008.12.010 1:STN:280:DC%2BD1M7kvVartg%3D%3D
44. W Walwyn S John M Maga, et al. 2009 Delta receptors are required for full inhibitory coupling of mu-receptors to voltage-dependent Ca(2+) channels in dorsal root ganglion neurons Mol Pharmacol 76 134 143 19357247 10.1124/mol.109.055913 1:CAS:528:DC%2BD1MXos1amt7o%3D
45. PY Law LJ Erickson-Herbrandson QQ Zha, et al. 2005 Heterodimerization of mu- and delta-opioid receptors occurs at the cell surface only and requires receptor-G protein interactions J Biol Chem 280 11152 11164 15657030 10.1074/jbc.M500171200 1:CAS:528:DC%2BD2MXisVyjsr8%3D (Pubitemid 40418422)
46. G Milligan 2008 A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization Br J Pharmacol 153 Suppl 1 S216 229 17965750 1:CAS:528:DC%2BD1cXislSjtro%3D
47. JS Chan TT Chiu YH Wong 1995 Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: coupling to multiple G proteins J Neurochem 65 2682 2689 7595566 10.1046/j.1471-4159.1995.65062682.x 1:CAS:528: DyaK2MXpsFersbY%3D
48. S Zhang L Yu 1995 Identification of dynorphins as endogenous ligands for an opioid receptor-like orphan receptor J Biol Chem 270 22772 22776 7559404 10.1074/jbc.270.39.22772 1:CAS:528:DyaK2MXosFOqurs%3D
49. SR Childers 1991 Opioid receptor-coupled second messenger systems Life Sci 48 1991 2003 1851914 10.1016/0024-3205(91)90154-4 1:CAS:528: DyaK3MXit1Smur0%3D
50. JC Meunier 1997 Nociceptin/orphanin FQ and the opioid receptor-like ORL1 receptor Eur J Pharmacol 340 1 15 9527501 10.1016/S0014-2999(97)01411-8 1:CAS:528:DyaK1cXmtVSgsw%3D%3D (Pubitemid 28033970)
51. RS Duman JF Tallman EJ Nestler 1988 Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus J Pharmacol Exp Ther 246 1033 1039 2843624 1:CAS:528:DyaL1cXmtVGitrc%3D
52. WF Simonds 1999 G protein regulation of adenylate cyclase Trends Pharmacol Sci 20 66 73 10101967 10.1016/S0165-6147(99)01307-3 1:CAS:528:DyaK1MXksVynsr8%3D (Pubitemid 29322313)
53. D Steiner T Avidor-Reiss E Schallmach, et al. 2005 Regulation of adenylate cyclase type VIII splice variants by acute and chronic Gi/o-coupled receptor activation Biochem J 386 341 348 15537392 10.1042/BJ20041670 1:CAS:528:DC%2BD2MXhsFSmsbs%3D (Pubitemid 40343792)
54. EJ Nestler BT Hope KL Widnell 1993 Drug addiction: a model for the molecular basis of neural plasticity Neuron 11 995 1006 8274284 10.1016/0896-6273(93)90213-B 1:CAS:528:DyaK2cXis1Sgsrk%3D (Pubitemid 24015274)
55. RY Chan YH Wong 1999 Chronic activation of ORL1 receptor induces supersensitization of adenylyl cyclase Neuroreport 10 2901 2905 10549794 10.1097/00001756-199909290-00005 1:CAS:528:DyaK1MXmsl2hsr8%3D (Pubitemid 29507750)
56. A Tempel RS Zukin 1987 Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography Proc Natl Acad Sci USA 84 4308 4312 3035579 10.1073/pnas.84.12. 4308 1:CAS:528:DyaL2sXksFagu7c%3D (Pubitemid 17090923)
57. K Fukuda S Kato K Mori, et al. 1994 cDNA cloning and regional distribution of a novel member of the opioid receptor family FEBS Lett 343 42 46 8163014 10.1016/0014-5793(94)80603-9 1:CAS:528:DyaK2cXkslCrtr8%3D (Pubitemid 24123943)
58. SB Lane-Ladd J Pineda VA Boundy, et al. 1997 CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence J Neurosci 17 7890 7901 9315909 1:CAS:528:DyaK2sXms1egurY%3D (Pubitemid 27426226)
59. V Zachariou R Liu Q LaPlant, et al. 2008 Distinct roles of adenylyl cyclases 1 and 8 in opiate dependence: behavioral, electrophysiological, and molecular studies Biol Psychiatry 63 1013 1021 18222416 10.1016/j.biopsych.2007. 11.021 1:CAS:528:DC%2BD1cXmtVagsr8%3D
60. MH Han CA Bolanos TA Green, et al. 2006 Role of cAMP response element-binding protein in the rat locus ceruleus: regulation of neuronal activity and opiate withdrawal behaviors J Neurosci 26 4624 4629 16641242 10.1523/JNEUROSCI.4701-05.2006 1:CAS:528:DC%2BD28XksFWqur0%3D (Pubitemid 44315362)
61. JL Cao VF Vialou MK Lobo, et al. 2010 Essential role of the cAMP-cAMP response-element binding protein pathway in opiate-induced homeostatic adaptations of locus coeruleus neurons Proc Natl Acad Sci U S A 107 17011 17016 20837544 10.1073/pnas.1010077107 1:CAS:528:DC%2BC3cXht1Ohu77P
62. JS Mogil JE Grisel RK Reinscheid, et al. 1996 Orphanin FQ is a functional anti-opioid peptide Neuroscience 75 333 337 8930999 10.1016/0306-4522(96)00338- 7 1:CAS:528:DyaK28XntVyntLk%3D (Pubitemid 26361325)
63. JR Shoblock J Wichmann NT Maidment 2005 The effect of a systemically active ORL-1 agonist, Ro 64-6198, on the acquisition, expression, extinction, and reinstatement of morphine conditioned place preference Neuropharmacology 49 439 446 15919100 10.1016/j.neuropharm.2005.04.008 1:CAS:528:DC%2BD2MXosVCrt78%3D (Pubitemid 41169968)
64. P Marquez AT Nguyen A Hamid, et al. 2008 The endogenous OFQ/N/ORL-1 receptor system regulates the rewarding effects of acute cocaine Neuropharmacology 54 564 568 18082848 10.1016/j.neuropharm.2007.11.003 1:CAS:528:DC%2BD1cXhsVSgt7s%3D
65. J Kotlinska P Rafalski G Biala, et al. 2003 Nociceptin inhibits acquisition of amphetamine-induced place preference and sensitization to stereotypy in rats Eur J Pharmacol 474 233 239 12921868 10.1016/S0014-2999(03) 02081-8 1:CAS:528:DC%2BD3sXmt1Kju7g%3D (Pubitemid 37281455)
66. SJ Heishman ML Stitzer GE Bigelow, et al. 1989 Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure J Pharmacol Exp Ther 248 127 134 2913267 1:CAS:528:DyaL1MXht1yntb4%3D (Pubitemid 19063479)